Format

Send to

Choose Destination
J Allergy Clin Immunol. 2019 Dec;144(6):1490-1494. doi: 10.1016/j.jaci.2019.10.010. Epub 2019 Oct 23.

Advances in eosinophilic diseases in 2018.

Author information

1
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
2
Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: Rothenberg@cchmc.org.

Abstract

Interest in eosinophil biology and eosinophilic diseases is increasing, as reflected in a doubling of the number of annual articles focused on this topic published in the Journal of Allergy and Clinical Immunology over the past decade. Although the majority of these publications relate to eosinophilic asthma, a growing proportion of them focus on breakthroughs in the diagnosis, treatment, and pathogenesis of other eosinophilic disorders, most notably eosinophilic esophagitis. This review highlights advances in our understanding of eosinophilia and eosinophilic disorders (excluding asthma) published in the Journal in 2018.

KEYWORDS:

Apoptosis; asthma; eosinophils; esophagitis; gastrointestinal and hypereosinophilic

PMID:
31655098
DOI:
10.1016/j.jaci.2019.10.010

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center